NextCure, Inc. (NXTC)
Nasdaq: NXTC · Pharmaceutical Preparations · Beltsville, MD · filing with the SEC since 2016
Who runs NextCure, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Richman Michael
President & CEO. First filing May 2019, latest Feb 3, 2026, 0 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
25 people on the record since 2019
Officerssales are open-market, Nov 9, 2025 to Nov 9, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Richman Michael | President & CEO | May 2019 | Feb 3, 2026 | none |
| Cobourn Steven P. | Chief Financial Officer | May 2019 | Feb 3, 2026 | none |
| Mayer Timothy | Chief Operating Officer | May 2019 | Feb 3, 2026 | none |
| Guha Udayan | Chief Medical Officer | Feb 2025 | Feb 3, 2026 | none |
| Kundu Sourav | Sr VP, Dev. & Mfg. | Jul 2021 | Feb 3, 2026 | none |
| Shaw Kevin G. | Sr VP, General Counsel | Feb 2023 | Feb 3, 2026 | none |
Directorssales are open-market, Nov 9, 2025 to Nov 9, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Borgman Anne Elizabeth | director | Oct 2021 | Jun 22, 2026 | none |
| Feigal Ellen | director | Oct 2021 | Jun 22, 2026 | none |
| Houston John G | director | Sep 2020 | Jun 22, 2026 | none |
| Jones Elaine V | director | May 2019 | Jun 22, 2026 | none |
| Kabakoff David S | director | May 2019 | Jun 22, 2026 | none |
| Webster Stephen W | director | May 2019 | Jun 22, 2026 | none |
Owners of more than 10% of a classsales are open-market, Nov 9, 2025 to Nov 9, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Adar1 Capital Management, LLC | 10% owner | Jul 2026 | Nov 9, 2026 | none |
| Schneeberger Daniel | 10% owner | Jul 2026 | Nov 9, 2026 | none |
| Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. | 10% owner | Sep 2025 | Aug 12, 2026 | 1 · $200,000 |
| Ren Jinsheng | 10% owner | Sep 2025 | Aug 12, 2026 | none |
| Simcere Pharmaceutical Group Ltd | 10% owner | Sep 2025 | Aug 12, 2026 | none |
| Simcere Zaiming Pharmaceutical Co., Ltd. | 10% owner | Sep 2025 | Aug 12, 2026 | none |
| Simcere Zaiming, Inc. | 10% owner | Aug 2025 | Aug 12, 2026 | none |
| Tang Renhong | 10% owner | Sep 2025 | Aug 12, 2026 | none |
Earlier names on the record22, newest filing first
Langermann Sol · officer · last filing Feb 2025Myint Han · officer · last filing Apr 2024Khuong Chau Quang · director · last filing Jun 2023Nicholson Garry A · director · last filing Jun 2023Liu Linda · officer · last filing Feb 2022Xu Stella · director · last filing Jun 2021Heller Kevin N. · officer · last filing Jul 2020Li Judith · director · last filing Jun 2020Morrison Briggs · director · last filing Jun 2020Bingham James B. · officer · last filing Mar 2020Healy James · 10% owner · last filing Nov 2019Mehra Anand · 10% owner · last filing Nov 2019Powell Michael · 10% owner · last filing Nov 2019Sofinnova Management Ix, L.L.C. · 10% owner · last filing Nov 2019Sofinnova Venture Partners Ix, L.P. · 10% owner · last filing Nov 2019Shannon Timothy M · director · last filing Jun 2019Orbimed Advisors LLC · director · last filing May 2019Orbimed Capital Gp Vi LLC · director · last filing May 2019Alexandria Venture Investments, LLC · 10% owner · last filing May 2019Canaan Partners X LLC · 10% owner · last filing May 2019Canaan X L.P. · 10% owner · last filing May 2019Quan Venture Fund II, L.P. · 10% owner · last filing May 2019
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.